Target intelligence / Profile preview

Colonization factor antigen CS6 (CS6)

Target
CS6
Molecular classification
Bacterial surface protein, Adhesin, Colonization factor
01

Overview

Colonization factor antigen CS6 (CS6) is a critical surface-associated protein complex expressed by enterotoxigenic Escherichia coli (ETEC), a primary bacterial cause of diarrhea in children in developing nations and travelers (Tobias et al., 2017, PubMed: 28137730). Unlike many other ETEC colonization factors that form hair-like fimbriae, CS6 is a non-fimbrial adhesin composed of two major structural subunits, CssA and CssB, which are essential for bacterial attachment to the human small intestinal epithelium (Wolf et al., 1997, PubMed: 9353905). This adherence is a mandatory step in ETEC pathogenesis, enabling the bacteria to colonize the gut and deliver enterotoxins that cause fluid secretion and diarrhea (Nicklasson et al., 2012, PubMed: 22564585). Because CS6 is one of the most prevalent colonization factors globally, it is a high-priority target for vaccine development, featuring prominently in multivalent oral vaccine candidates like ETVAX (Svennerholm & Lundgren, 2012, PubMed: 23074018). Therapeutic strategies focus on eliciting a robust mucosal immune response, specifically secretory IgA, to block CS6-mediated colonization and prevent disease (Svennerholm, 2011, PubMed: 21477141).

Other names
CS6 antigenColonization factor antigen VICFA/VICssA/CssB complexCS6 adhesin
02

Mechanism of action

Inhibition of bacterial adhesion to host intestinal epithelial cells through the induction of specific mucosal antibodies (primarily secretory IgA) that target the CS6 surface protein complex (Svennerholm, 2011, PubMed: 21477141).

03

Biological functions

Bacterial adhesionIntestinal colonizationHost-pathogen interaction
04

Disease associations

Enterotoxigenic Escherichia coli infectionTraveler's diarrheaChildhood diarrheaInfection
05

Safety considerations

Oral vaccine stability in gastric acidAntigenic diversity of ETEC strainsPotential for interference between multiple vaccine antigensLower immune response in infants in low-to-middle-income countries (LMICs)
06

Interacting drugs

ETVAX

2 more in the full profile.

07

Biomarkers

Anti-CS6 secretory IgA (sIgA) titersAnti-CS6 Antibody in Lymphocyte Secretions (ALS)Serum anti-CS6 IgG levelsCS6-positive ETEC detection in stool

Beyond the preview

Go deeper on Colonization factor antigen CS6 (CS6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonization factor antigen CS6 (CS6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call